Evommune EVMN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | $564.08K+36.0% | ||
| —— | —— | —— | —— | ||
| $1.05M-12.4% | $1.2M— | —— | —— | ||
| —— | $123.75K-35.8% | $192.81K— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Evommune generate?
- Evommune (EVMN) generated -$2.9M in operating cash flow over the trailing twelve months.
- Where does Evommune 's cash flow data come from?
- Every line is extracted from Evommune 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
